[Pure red cell aplasia associated with chronic lymphocytic leukaemic successfully treated with rituximab].
Jiménez-Gonzalo
Francisco José
FJ
Ríos-Herranz
Eduardo
E
García-Donas Gabaldón
Gloria
G
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D012010:Red-Cell Aplasia, Pure / Q000150:complications*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab